Clinical evaluation of methdilazine hydrochloride, a new antihistamine, using double-blind and placebo control.
D018926:Anti-Allergic Agents; D004311:Double-Blind Method; D006634:Histamine H1 Antagonists / Q000628:therapy*; D006979:Hyperthermia, Induced; D010640:Phenothiazines; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy*
D018926:Anti-Allergic Agents; D006634:Histamine H1 Antagonists; D010640:Phenothiazines; C044642:methdilazine
ANTIHISTAMINICS/therapy; HAY FEVER/therapy